Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Ishita Drugs And Industries Limited, is a listed public company incorporated on 05 February, 1992. It is classified as a public limited company and is located in , Gujarat. It's authorized share capital is INR 6.00 cr and the total paid-up capital is INR 2.99 cr.
Ishita Drugs And Industries Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 19.26% over the previous year. At the same time, it's book networth has increased by 8.16%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Jagdishprasad Agrawal Gokulchand
Shareholder
|
01031687 | 34 years |
| Director | Abha Agrawal Jagdishprasad
Shareholder
|
01589479 | 34 years |
| Director | Arvind Vilasrao Sapkal | 08607096 | 6 years |
| Director | Dhwani Jaspalsinh Solanki | 10299290 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 4.2 cr
Corporation Bank
No. of Loans: 1
Total Amount : 1.8 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ISHITA OVERSEAS PRIVATE LIMITED |
Active
|
2.3 L | 2 | Gujarat |
| UMANG FINANCIAL SERVICES LIMITED |
Active
|
27.0 L | 1 | Gujarat |
| ANVI LIFESCIENCES PRIVATE LIMITED |
Active
|
75.0 L | 1 | Gujarat |
| MJM ENGINEERING SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| HAZOOR MULTI PROJECTS LIMITED |
Active
|
22.5 Cr | 1 | |
| RACHANA INFRASTRUCTURE LIMITED |
Active
|
18.6 Cr | 1 | Gujarat |
Read more
The incorporation date of ISHITA DRUGS AND INDUSTRIES LIMITED is 05 February, 1992
The authorized share capital of ISHITA DRUGS AND INDUSTRIES LIMITED is INR ₹ 6.0 Cr.
The paid-up capital of ISHITA DRUGS AND INDUSTRIES LIMITED is INR ₹ 3.0 Cr.
The registered address of ISHITA DRUGS AND INDUSTRIES LIMITED is SURVEY NO 179/1, VASNA-IYAVA, TALUKA SANAND, AHMEDABAD, Gujarat, India, 382210 - 382210
The CIN number of ISHITA DRUGS AND INDUSTRIES LIMITED is L24231GJ1992PLC017054.